9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9171B |
Ethosuximide Screen, Blood |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9171U |
Ethosuximide Screen, Urine |
9190B |
Ketoacidosis Screen, Postmortem, Blood (Forensic) |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9233B |
Phensuximide Screen, Blood |
9233U |
Phensuximide Screen, Urine |
9237U |
Phenylpropanolamine Screen, Urine |
9248B |
Pseudoephedrine Screen, Blood |
9248SP |
Pseudoephedrine Screen, Serum/Plasma |
9248U |
Pseudoephedrine Screen, Urine |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9416B |
Phenobarbital Screen, Blood |